EXELA TECHNOLOGIES, INC. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-09-30..
- Stock-based compensation / revenue · 12 months: Value 0.19%; Formula and calculation Share-based compensation / revenue. Period ending 2024-09-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.19% | Share-based compensation / revenue. Period ending 2024-09-30. $1.93M ÷ $1.04B × 100 ≈ 0.19% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 1.04B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.93M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.57M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | (m) | $1.04B | $1.93M | $2.57M | (m) | (m) | 0.19% | (m) | (m) |
| 2024-06-30 | (m) | $1.02B | $1.36M | $1.44M | (m) | (m) | 0.13% | (m) | (m) |
| 2024-03-31 | (m) | $1.05B | $1.19M | $15.02M | (m) | (m) | 0.11% | (m) | (m) |
| 2023-12-31 | $1.20M | $1.06B | $115.00K | $8.05M | (m) | 0.11% | 0.01% | (m) | (m) |
| 2023-09-30 | (m) | $1.07B | $842.00K | $-146.67M | (m) | (m) | 0.08% | (m) | (m) |
| 2023-06-30 | (m) | $1.08B | $448.00K | $-196.23M | (m) | (m) | 0.04% | (m) | (m) |
| 2023-03-31 | (m) | $1.07B | $773.00K | $-228.33M | (m) | (m) | 0.07% | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.10B | $3.12M | $-86.39M | (m) | (m) | 0.28% | (m) | (m) |
| 2022-06-30 | (m) | $1.12B | $3.80M | $-36.49M | (m) | (m) | 0.34% | (m) | (m) |
| 2022-03-31 | (m) | $1.15B | $3.86M | $9.77M | (m) | (m) | 0.34% | (m) | (m) |
| 2021-12-31 | $1.30M | $1.17B | $3.94M | $21.39M | (m) | 0.11% | 0.34% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.29B | (m) | $-16.42M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.56B | (m) | $-321.22M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.59B | (m) | $-10.70M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | $6.81M | $-26.12M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $7.42M | $-107.09M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $1.32B | $7.39M | $-104.30M | (m) | (m) | 0.56% | (m) | (m) |
| 2017-12-31 | (m) | $1.15B | (m) | $-99.53M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $978.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $826.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $808.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $789.93M | (m) | $50.24M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $54.73M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $1.70M | $805.23M | $8.12M | $40.31M | (m) | 0.21% | 1.01% | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.